NCT03542344View on ClinicalTrials.gov

This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

August 24, 2018

Study Completion Date

August 24, 2018

Conditions
Healthy
Interventions
DRUG

BI 1015550

Single rising oral dose

DRUG

Placebo

Single rising oral dose

Trial Locations (1)

133-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03542344 - This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated. | Biotech Hunter | Biotech Hunter